Accéder au contenu
Merck

Tenoten in the therapy of anxious disturbances in patients with essential hypertension and coronary heart disease.

Bulletin of experimental biology and medicine (2009-12-23)
N P Vanchakova, A P Popov
RÉSUMÉ

The study demonstrated high anxiolytic activity of tenoten, which was not inferior to the anxiolytic effect of grandaxin. The positive changes persisted after termination of treatment in the tenoten group (but not in grandaxin group). Tenoten can be recommended for the treatment of patients with cardiovascular diseases associated with neurotic disturbances.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Tofisopam, ≥98% (HPLC), solid